Gao Daming, Inuzuka Hiroyuki, Tseng Alan, Chin Rebecca Y, Toker Alex, Wei Wenyi
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Nat Cell Biol. 2009 Apr;11(4):397-408. doi: 10.1038/ncb1847. Epub 2009 Mar 8.
Deregulated Skp2 function promotes cell transformation, and this is consistent with observations of Skp2 overexpression in many human cancers. However, the mechanisms underlying elevated Skp2 expression are still unknown. Here we show that the serine/threonine protein kinase Akt1, but not Akt2, directly controls Skp2 stability by a mechanism that involves degradation by the APC-Cdh1 ubiquitin ligase complex. We show further that Akt1 phosphorylates Skp2 at Ser 72, which is required to disrupt the interaction between Cdh1 and Skp2. In addition, we show that Ser 72 is localized within a putative nuclear localization sequence and that phosphorylation of Ser 72 by Akt leads to cytoplasmic translocation of Skp2. This finding expands our knowledge of how specific signalling kinase cascades influence proteolysis governed by APC-Cdh1 complexes, and provides evidence that elevated Akt activity and cytoplasmic Skp2 expression may be causative for cancer progression.
Skp2功能失调促进细胞转化,这与在许多人类癌症中观察到的Skp2过表达情况一致。然而,Skp2表达升高的潜在机制仍不清楚。在此我们表明,丝氨酸/苏氨酸蛋白激酶Akt1而非Akt2,通过一种涉及APC-Cdh1泛素连接酶复合体介导的降解机制直接控制Skp2的稳定性。我们进一步表明,Akt1在Ser 72位点磷酸化Skp2,这是破坏Cdh1与Skp2之间相互作用所必需的。此外,我们表明Ser 72位于一个假定的核定位序列内,并且Akt对Ser 72的磷酸化导致Skp2的细胞质易位。这一发现扩展了我们对特定信号激酶级联如何影响由APC-Cdh1复合体控制的蛋白水解的认识,并提供了证据表明Akt活性升高和细胞质Skp2表达可能是癌症进展的原因。